Date: Thursday, March 6, 2025 Time: 2:00 p.m. to 3:30 p.m. ET Location: Free online event
The Drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In January 2025, we published a consultation document…
Date: Tuesday, March 4, 1:00 p.m. to 2:00 p.m. ETLocation: Free online event
In support of the Government of Canada’s National Strategy for Drugs for Rare Diseases, Canada’s Drug Agency established a Newborn Screening Advisory Panel to develop pan-Canadian guidance for decision-makers about newborn…
Date: Tuesday, February 4, 2025 Time: 1:00 p.m. to 2:00 p.m. ET
Canada’s Drug Agency is finalizing a strategy to advance the appropriate use of prescription medications. The strategy will guide us in developing a collaborative, coordinated, pan-Canadian approach to appropriate use and build…
Date: January 26 to 28, 2025 Location: Cascais, Portugal
Nicole Mittmann, Chief Scientist and Vice-President of Scientific Evidence, Methodologies, and Resources, and Dan Singh, Director of Strategy and Innovation, will represent Canada’s Drug Agency at the 2025 HTAi Global Policy Forum in…
Date: Tuesday, January 21, 2025 Time: 9:00 a.m. to 5:00 p.m. (ET) Location: 101 Lyon Street North, Ottawa
The Canadian Association for Healthcare Reimbursement hosts its annual National Day and Sudha Kutty, Executive Vice-President, Evidence, Products, and Services, will speak on behalf…
Date: Wednesday, January 15, 2025 Time: 1:00 p.m. to 2:00 p.m. ET Location: 2nd Floor Council Chambers, 865 Carling Avenue, Ottawa or attend virtually
Is the role of economic evaluations in health care misunderstood? Recent debates have raised questions about their role in shaping…
Date: Tuesday, December 17Time: 2:00 p.m. to 3:15 p.m. ET
The Drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In June 2023, we signalled program improvements that could be explored or added to the process. Since…
Date: December 11 to 12
Location: Toronto
Elena Lungu, Director, Data Systems and Analytics at Canada’s Drug Agency will be speaking at the session entitled Building Credibility in Real-World Evidence for Better Patient Outcomes at the 12th Annual Data Analytics for Healthcare…
Date: November 26 to 27Location: Montreal
Trish Caetano, Director, Drug Data Services and Analytics will represent Canada’s Drug Agency at the CORD Fall 2024 Rare Diseases Conference in Montreal.
Date: November 14 to 15Location: Gatineau
Matthew McDonald, Director, Pharmaceutical Policy and Health Technology Assessment at Canada’s Drug Agency, will be speaking during the session, Innovative Pathways to HTA, on November 14 at the DIA Canada Annual Meeting.